Cytokinetics
CYTK
#2280
Rank
S$10.40 B
Marketcap
S$85.10
Share price
-1.31%
Change (1 day)
26.15%
Change (1 year)

Cytokinetics (CYTK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$2.53 Billion

According to Cytokinetics 's latest financial reports the company's total liabilities are S$2.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cytokinetics - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$2.08 B30.67%
2023-12-31S$1.59 B6.23%
2022-12-31S$1.50 B86.34%
2021-12-31S$0.80 B45.22%
2020-12-31S$0.55 B37.17%
2019-12-31S$0.40 B60.22%
2018-12-31S$0.25 B2.29%
2017-12-31S$0.24 B125.56%
2016-12-31S$0.10 B66.22%
2015-12-31S$65.98 M22.08%
2014-12-31S$54.04 M48.4%
2013-12-31S$36.42 M298.9%
2012-12-31S$9.13 M53.43%
2011-12-31S$5.95 M-38.21%
2010-12-31S$9.62 M-67.6%
2009-12-31S$29.72 M-44.85%
2008-12-31S$53.89 M-32.46%
2007-12-31S$79.79 M-17.66%
2006-12-31S$96.91 M225.18%
2005-12-31S$29.8 M-11.08%
2004-12-31S$33.51 M-87.26%
2003-12-31S$0.26 B29.91%
2002-12-31S$0.20 B-5.96%
2001-12-31S$0.21 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
S$0.68 B-73.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
S$55.07 M-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$0.34 B-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.34 B 4,013.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$1.56 B-38.37%๐Ÿ‡บ๐Ÿ‡ธ USA